nihms953688.pdf (721.18 kB)
A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases
journal contributionposted on 2020-10-15, 08:46 authored by Anne Montfort, Oliver Pearce, Eleni Maniati, Benjamin G Vincent, Lisa Bixby, Steffen Böhm, Thomas Dowe, Edmund H Wilkes, Probir Chakravarty, Richard Thompson, Joanne Topping, Pedro R Cutillas, Michelle Lockley, Jonathan S Serody, Melania Capasso, Frances R Balkwill
PURPOSE: In high-grade serous ovarian cancer (HGSOC), higher densities of both B cells and the CD8+ T-cell infiltrate were associated with a better prognosis. However, the precise role of B cells in the antitumor response remains unknown. As peritoneal metastases are often responsible for relapse, our aim was to characterize the role of B cells in the antitumor immune response in HGSOC metastases. EXPERIMENTAL DESIGN: Unmatched pre and post-chemotherapy HGSOC metastases were studied. B-cell localization was assessed by immunostaining. Their cytokines and chemokines were measured by a multiplex assay, and their phenotype was assessed by flow cytometry. Further in vitro and in vivo assays highlighted the role of B cells and plasma cell IgGs in the development of cytotoxic responses and dendritic cell activation. RESULTS: B cells mainly infiltrated lymphoid structures in the stroma of HGSOC metastases. There was a strong B-cell memory response directed at a restricted repertoire of antigens and production of tumor-specific IgGs by plasma cells. These responses were enhanced by chemotherapy. Interestingly, transcript levels of CD20 correlated with markers of immune cytolytic responses and immune complexes with tumor-derived IgGs stimulated the expression of the costimulatory molecule CD86 on antigen-presenting cells. A positive role for B cells in the antitumor response was also supported by B-cell depletion in a syngeneic mouse model of peritoneal metastasis. CONCLUSIONS: Our data showed that B cells infiltrating HGSOC omental metastases support the development of an antitumor response. Clin Cancer Res; 23(1); 250-62. ©2016 AACR.
Antibody FormationAntineoplastic Combined Chemotherapy ProtocolsB-LymphocytesBiomarkersCell Line, TumorCystadenocarcinoma, SerousCytokinesDendritic CellsFemaleHumansImmunohistochemistryImmunologic MemoryImmunophenotypingLymphocytes, Tumor-InfiltratingNeoplasm GradingNeoplasm MetastasisNeoplasm StagingOvarian NeoplasmsProteomeProteomicsCB1112 Oncology and CarcinogenesisOncology & Carcinogenesis